Articles by Emmanuel Aris, PhD

Antibody Persistence for up to 5 Years After a Fourth Dose of Haemophilus influenzae Type b and Neisseria Meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine...

Marshall, Gary S.; Blatter, Mark; Marchant, Colin; More

Pediatric Infectious Disease Journal. 32(6):662-668, June 2013.

Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine

Nolan, Terry; Richmond, Peter; Marshall, Helen; More

Pediatric Infectious Disease Journal. 30(3):190-196, March 2011.

IMMUNE RESPONSE AND ONE-YEAR ANTIBODY PERSISTENCE AFTER A FOURTH DOSE OF A NOVEL HAEMOPHILUS INFLUENZAE TYPE B AND NEISSERIA MENINGITIDIS SEROGROUPS C AND Y-TETANUS TOXOID...

Marshall, Gary S.; Marchant, Colin D.; Blatter, Mark; More

Pediatric Infectious Disease Journal. 29(5):469-471, May 2010.

Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants

Marchant, Colin D.; Miller, Jacqueline M.; Marshall, Gary S.; More

Pediatric Infectious Disease Journal. 29(1):48-52, January 2010.